Update on the diagnosis and management of Parkinson's disease
- PMID: 32675145
- PMCID: PMC7385761
- DOI: 10.7861/clinmed.2020-0220
Update on the diagnosis and management of Parkinson's disease
Abstract
Parkinson's disease (PD) is diagnosed where bradykinesia occurs together with rigidity or tremor, in the presence of supporting features. The diagnosis is clinical, and attention should be paid to exclusion criteria indicating an alternative diagnosis and to 'red flag' features. There is no cure or disease-modifying treatment for PD, and the rate of progression is variable. The most effective symptomatic treatment remains levodopa, which has superior benefits for quality of life in early PD compared to other therapies. Motor fluctuations and dyskinesia later in the disease course can be improved with adjunctive treatments. Around 10% of patients per year with refractory motor fluctuations may be eligible for advanced therapies, including deep-brain stimulation surgery. There is emerging evidence for the management of non-motor symptoms in PD, and the importance of multidisciplinary care. In this article, the evidence base for optimal diagnosis and management of PD is discussed.
Keywords: Parkinson's disease; diagnosis; levodopa; non-motor symptoms; treatment.
© Royal College of Physicians 2020. All rights reserved.
Figures
References
-
- Parkinson's UK The incidence and prevalence of Parkinson's in the UK report. Parkinson's UK, 2017.
-
- Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord 2015;30:1591–601. - PubMed
-
- Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140–8. - PubMed
-
- National Institute for Health and Care Excellence Parkinson's disease in adults: diagnosis and management: NICE guideline [NG71]. NICE, 2017.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical